FDA "Stakeholder" Meetings To Feature Henney, CBER Device Action Plan
This article was originally published in The Gray Sheet
Executive SummaryFDA's Center for Biologics Evaluation and Research will formally unveil its action plan for regulating medical devices on April 28 during the center's "stakeholder" meetings.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.